MLB notebook: Verlander expected to make next start
• Detroit ace Justin Verlander is expected to make his next start despite a blister on his pitching thumb. He left Thursday's game against Kansas City after seven innings.
• The South Florida anti-aging clinic Biogenesis, suspected by MLB investigators of being a source of performance-enhancing drugs for more than 30 players, including Alex Rodriguez and Melky Cabrera, in some instances obtained the banned substances through forged prescription forms, according to an ESPN report.
• Marlins owner Jeffrey Loria denied instructing his baseball staff to flip-flop starting pitchers in a doubleheader Tuesday against the Twins, FoxSports reported. “I had nothing to do with the decision,” Loria said. Marlins veteran free-agent-to-be Ricky Nolasco originally was scheduled to pitch the opener and promising rookie Jose Fernandez the nightcap. A Yahoo! report said Loria ordered the switch because the temperature for the day game was expected to be warmer.
• The Blue Jays scratched Josh Johnson from his Friday start against the Yankees because of right triceps tightness.
• Yankees catcher Francisco Cervelli left New York's game against the Blue Jays after being hit on the right hand by a foul tip with the fifth pitch of the first inning.
• Home plate umpire Brian O'Nora exited the Phillies-Mets game in the first inning because of flulike symptoms, resulting in a nine-minute delay.
Show commenting policy
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.